Psycler - pedaling through the psycho babble of a media distorted reality
I have a lot to say about a lot of things. I think the world is a fucked up place and we're all under the influence of mind control and social conditioning via the use of media, religion, education and chemically induced genetic manipulation.If you can't understand me then you have been programmed and are sadly lost to us.
If you understand me then ask yourself what you did today to change things and that's the best you can do.
Wednesday, September 13, 2006
USATODAY.com - FDA whistle-blower Graham blasts new Merck arthritis drug:
"The arthritis drug that Merck has developed to compete with Celebrex may be as risky for the heart as Vioxx, writes Food and Drug Administration whistle-blower David Graham in an editorial posted online Tuesday by a medical journal.
In considering whether Arcoxia should be approved, 'the FDA, academia, and the medical research enterprise are once again faced with the opportunity to forsake common sense by willfully accepting misdirection and disinformation presented in the guise of science,' Graham writes on the Journal of the American Medical Association's website.
An editor's note says the FDA allowed Graham to write the editorial as a private citizen, not as an agency employee. The editorial and the two studies it accompanies will run in the Oct. 4 JAMA, but they were posted online early 'because of the public health implications,' a JAMA press release says."
"The arthritis drug that Merck has developed to compete with Celebrex may be as risky for the heart as Vioxx, writes Food and Drug Administration whistle-blower David Graham in an editorial posted online Tuesday by a medical journal.
In considering whether Arcoxia should be approved, 'the FDA, academia, and the medical research enterprise are once again faced with the opportunity to forsake common sense by willfully accepting misdirection and disinformation presented in the guise of science,' Graham writes on the Journal of the American Medical Association's website.
An editor's note says the FDA allowed Graham to write the editorial as a private citizen, not as an agency employee. The editorial and the two studies it accompanies will run in the Oct. 4 JAMA, but they were posted online early 'because of the public health implications,' a JAMA press release says."
Archives
May 2006 July 2006 August 2006 September 2006 October 2006 November 2006 March 2007 June 2007 May 2008 June 2008 July 2008 September 2008 November 2008 December 2008 October 2009 November 2009 February 2010 March 2010 April 2010
Subscribe to Posts [Atom]